These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 36594508)

  • 41. Structural Basis of the Potential Binding Mechanism of Remdesivir to SARS-CoV-2 RNA-Dependent RNA Polymerase.
    Zhang L; Zhou R
    J Phys Chem B; 2020 Aug; 124(32):6955-6962. PubMed ID: 32521159
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rapid Diagnosis of Coronavirus by RNA-Directed RNA Transcription Using an Engineered RNA-based Platform.
    Han S; Ko O; Lee G; Jeong SW; Choi YJ; Lee JB
    Nano Lett; 2021 Jan; 21(1):462-468. PubMed ID: 33395304
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The G-Quadruplex/Helicase World as a Potential Antiviral Approach Against COVID-19.
    Panera N; Tozzi AE; Alisi A
    Drugs; 2020 Jul; 80(10):941-946. PubMed ID: 32451923
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A computational comparative analysis of the binding mechanism of molnupiravir's active metabolite to RNA-dependent RNA polymerase of wild-type and Delta subvariant AY.4 of SARS-CoV-2.
    Celik I; Tallei TE
    J Cell Biochem; 2022 Apr; 123(4):807-818. PubMed ID: 35132671
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Analysis of SARS-CoV-2 RNA-dependent RNA polymerase as a potential therapeutic drug target using a computational approach.
    Aftab SO; Ghouri MZ; Masood MU; Haider Z; Khan Z; Ahmad A; Munawar N
    J Transl Med; 2020 Jul; 18(1):275. PubMed ID: 32635935
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In Silico Identification of a Potent Arsenic Based Approved Drug Darinaparsin against SARS-CoV-2: Inhibitor of RNA Dependent RNA polymerase (RdRp) and Essential Proteases.
    Chowdhury T; Roymahapatra G; Mandal SM
    Infect Disord Drug Targets; 2021; 21(4):608-618. PubMed ID: 32718300
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In silico analysis of RNA-dependent RNA polymerase of the SARS-CoV-2 and therapeutic potential of existing antiviral drugs.
    Mondal SK; Mukhoty S; Kundu H; Ghosh S; Sen MK; Das S; Brogi S
    Comput Biol Med; 2021 Aug; 135():104591. PubMed ID: 34216889
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Replication-Dependent Biogenesis of Turnip Crinkle Virus Long Noncoding RNAs.
    Zhang S; Sun R; Perdoncini Carvalho C; Han J; Zheng L; Qu F
    J Virol; 2021 Aug; 95(18):e0016921. PubMed ID: 34160262
    [TBL] [Abstract][Full Text] [Related]  

  • 49. CNBP Binds and Unfolds In Vitro G-Quadruplexes Formed in the SARS-CoV-2 Positive and Negative Genome Strands.
    Bezzi G; Piga EJ; Binolfi A; Armas P
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33807682
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Methyltransferase-like 3 Modulates Severe Acute Respiratory Syndrome Coronavirus-2 RNA N6-Methyladenosine Modification and Replication.
    Zhang X; Hao H; Ma L; Zhang Y; Hu X; Chen Z; Liu D; Yuan J; Hu Z; Guan W
    mBio; 2021 Aug; 12(4):e0106721. PubMed ID: 34225491
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The potential chemical structure of anti-SARS-CoV-2 RNA-dependent RNA polymerase.
    Lung J; Lin YS; Yang YH; Chou YL; Shu LH; Cheng YC; Liu HT; Wu CY
    J Med Virol; 2020 Jun; 92(6):693-697. PubMed ID: 32167173
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Detecting and Profiling Endogenous RNA G-Quadruplexes in the Human Transcriptome.
    Zhang R; Liu Y; Zhang X; Xiao K; Hou Y; Liu H; Sun X
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360778
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The mechanism of RNA capping by SARS-CoV-2.
    Park GJ; Osinski A; Hernandez G; Eitson JL; Majumdar A; Tonelli M; Henzler-Wildman K; Pawłowski K; Chen Z; Li Y; Schoggins JW; Tagliabracci VS
    Nature; 2022 Sep; 609(7928):793-800. PubMed ID: 35944563
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Modeling the Enzymatic Mechanism of the SARS-CoV-2 RNA-Dependent RNA Polymerase by DFT/MM-MD: An Unusual Active Site Leading to High Replication Rates.
    Bignon E; Monari A
    J Chem Inf Model; 2022 Sep; 62(17):4261-4269. PubMed ID: 35982544
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cordycepin as a Promising Inhibitor of SARS-CoV-2 RNA Dependent RNA Polymerase (RdRp).
    Bibi S; Hasan MM; Wang YB; Papadakos SP; Yu H
    Curr Med Chem; 2022; 29(1):152-162. PubMed ID: 34420502
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Potential Candidates against COVID-19 Targeting RNA-Dependent RNA Polymerase: A Comprehensive Review.
    Agrawal N; Goyal A
    Curr Pharm Biotechnol; 2022; 23(3):396-419. PubMed ID: 33882805
    [TBL] [Abstract][Full Text] [Related]  

  • 57. On the Recognition of Natural Substrate CTP and Endogenous Inhibitor ddhCTP of SARS-CoV-2 RNA-Dependent RNA Polymerase: A Molecular Dynamics Study.
    Parise A; Ciardullo G; Prejanò M; Lande A; Marino T
    J Chem Inf Model; 2022 Oct; 62(20):4916-4927. PubMed ID: 36219674
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Different selection dynamics of S and RdRp between SARS-CoV-2 genomes with and without the dominant mutations.
    Koçhan N; Eskier D; Suner A; Karakülah G; Oktay Y
    Infect Genet Evol; 2021 Jul; 91():104796. PubMed ID: 33667722
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Enzymatic and nonenzymatic functions of viral RNA-dependent RNA polymerases within oligomeric arrays.
    Spagnolo JF; Rossignol E; Bullitt E; Kirkegaard K
    RNA; 2010 Feb; 16(2):382-93. PubMed ID: 20051491
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir.
    Yin W; Mao C; Luan X; Shen DD; Shen Q; Su H; Wang X; Zhou F; Zhao W; Gao M; Chang S; Xie YC; Tian G; Jiang HW; Tao SC; Shen J; Jiang Y; Jiang H; Xu Y; Zhang S; Zhang Y; Xu HE
    Science; 2020 Jun; 368(6498):1499-1504. PubMed ID: 32358203
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.